Investmark Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.87M Sell
19,920
-344
-2% -$80.1K 2.08% 10
2025
Q4
$4.19M Sell
20,264
-19
-0.1% -$3.76K 1.79% 14
2025
Q3
$3.76M Buy
20,283
+263
+1% +$45.1K 1.63% 18
2025
Q2
$3.06M Sell
20,020
-613
-3% -$94.2K 1.43% 20
2025
Q1
$3.42M Buy
20,633
+159
+0.8% +$24.9K 1.69% 18
2024
Q4
$2.96M Buy
20,474
+606
+3% +$93.9K 1.45% 21
2024
Q3
$3.22M Buy
19,868
+403
+2% +$64.2K 1.56% 18
2024
Q2
$2.85M Sell
19,465
-76
-0.4% -$11.3K 1.52% 21
2024
Q1
$3.09M Sell
19,541
-424
-2% -$67.5K 1.7% 15
2023
Q4
$3.13M Buy
19,965
+43
+0.2% +$6.59K 1.84% 13
2023
Q3
$3.1M Sell
19,922
-1,333
-6% -$220K 2.1% 13
2023
Q2
$3.52M Buy
21,255
+211
+1% +$34.1K 2.35% 12
2023
Q1
$3.26M Buy
21,044
+1,366
+7% +$221K 2.4% 13
2022
Q4
$3.48M Buy
19,678
+854
+5% +$147K 2.58% 11
2022
Q3
$3.08M Buy
18,824
+836
+5% +$141K 2.76% 10
2022
Q2
$3.19M Buy
17,988
+443
+3% +$78.9K 3.16% 11
2022
Q1
$3.11M Buy
17,545
+588
+3% +$100K 3.21% 11
2021
Q4
$2.9M Buy
+16,957
New +$2.78M 2.71% 11

Other funds holding JNJ

Investmark Advisory Group's JNJ Position: Q1 2026 in Review

Investmark Advisory Group reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, selling an estimated $80.1K and leaving 19,920 shares worth $4.87M. The position accounts for 2.08% of the portfolio, ranked #10.

Investmark Advisory Group first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Investmark Advisory Group held 19,920 shares of Johnson & Johnson worth $4.87M as of Q1 2026.
  • Investmark Advisory Group sold 344 Johnson & Johnson shares in Q1 2026, an estimated $80.1K.
  • Johnson & Johnson made up 2.08% of Investmark Advisory Group's portfolio in Q1 2026, its #10 holding.
  • Investmark Advisory Group first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Investmark Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.